1. Home
  2. > Pharmaceutical Market Trends
Global Fill Finish Manufacturing Market Size, Share & Industry Trends Analysis Report By End User, By Product, By Regional Outlook and Forecast, 2022 – 2028

Global Fill Finish Manufacturing Market Size, Share & Industry Trends Analysis Report By End User, By Product, By Regional Outlook and Forecast, 2022 – 2028

  • September 2022
  • 304 pages
  • ID: 6352738
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The Global Fill Finish Manufacturing Market size is expected to reach $16.1 billion by 2028, rising at a market growth of 9.5% CAGR during the forecast period.

The fill-finish step, which is probably the most important, brings the entire drug production process to a close. It comes after upstream bioprocessing, often known as the process of making the active ingredient through cell culture or fermentation. Additionally, it happens following downstream purification. Fill-Finish is a largely industrial activity that is still in its infancy but focuses on effective product composition and packaging.

Fill-finish involves intricate mechanical engineering filling, fluid, and solid pouring, and sealing systems—far more so than bioprocessing. A sterile medicine is delivered from filling needles to a sterile container, typically a vial or prefilled syringe, in an aseptic fill finish. The stopping (closing) of a container usually happens later, except in situations where medicine needs to be sterilely compressed.

It is a crucial step in the production of biopharmaceuticals. It is crucial to recognize how crucial these later-stage growth processes are. Innovation could be a silent killer, especially in a fill-finish process. But because fill-finish is so crucial to the biopharmaceutical production process, even the tiniest errors frequently result in product failure, which equals a total loss for a product that is already pricey.

Consumers depend on drugs like vaccines, nasal sprays, ear drops, and eye drops to be sterile, sanitary, and free from contamination almost every day. Parenteral products can have major negative effects, such as a fever or infection, if something non-sterile is added to the eye, or injected into muscle, skin, or vein. This is because parenteral products are given through injection or introduction to fragile mucus membranes.

COVID-19 Impact Analysis

COVID-19, and other recent pandemics and pandemics have brought to light the urgent need for vaccines and treatments to fight newly emerging and reemerging infectious illnesses. The manufacture of vaccines therefore urgently requires fill-finish services. Since CDMOs/CMOs often outsource fill-finish activities, these businesses are well-equipped to manage fill-finish of COVID-19 vaccinations as they begin to enter the market. Catalent is an example of a producer who can successfully grow up and meet demand of the market.

Market Growth Factors

Fill-Finish Manufacturing Techniques Are Advancing Technologically

The uses of isolators and restricted-access barrier systems (RABS), which establish reliable sterile manufacturing environments and successfully isolate human operators from the fill-finish process, is a technological achievement in aseptic fill-finish operations. Barrier isolation systems, which are combined fill-finish machines capable of performing all steps of fill-finish processes, are being developed by many device manufacturers in the fill-finish manufacturing sector.

Developing Industries Of Fill Finish Manufacturing

Manufacturers have been able to increase capabilities by utilizing technology aimed at reducing costs and amortizing capital investments over several products due to the emergence of biologic drugs regulatory paths. The need for locally produced biologics is being driven by rising living standards around the world as well as the desire of many governments to have enough vaccine and biologic manufacturing to service their populations.

Market Restraining Factors

Maintaining Sterility In A Fill-Finish Manufacturing Operation Can Be Difficult

Compared to non-sterile processes, aseptic fill-finish operations are more dangerous. For process execution, they need careful planning, qualified employees, and specialized facilities & equipment. Maintaining sterility is crucial because any contamination can result in significant financial losses and have a profound impact on the lives of patients. All of the components in aseptic fill-finishing operations must be sanitized before use. Sterility of the product is essential for assuring patient safety while using it.

Product Outlook

Based on the Product, the Fill Finish Manufacturing Market is segmented into Consumables (Prefilled syringes, Vials, cartridges, and others), Instruments (Systems and machine types). The instruments segment witnessed a significant revenue share in the fill-finish manufacturing market in 2021. A variety of low-maintenance washers with a 1000-fold reduction in particles are available for production with modest to high throughput.

End User Outlook

On the basis of End User, the Fill Finish Manufacturing Market is divided into Pharmaceutical & Biopharmaceutical Companies, Contract Manufacturing Organizations, and Other. The pharmaceutical & biopharmaceutical companies segment garnered the largest revenue share in the fill finish manufacturing market in 2021. The primary driver of market expansion is an increase in the production of pharmaceuticals and vaccines.

Regional Outlook

Region-wise, the Fill Finish Manufacturing Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment acquired the highest revenue share in the fill finish manufacturing market in 2021. By making biologics more affordable to use, factors like established reimbursement systems for medications have increased the demand for them among patients.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickson, and Company, Gerresheimer AG, Syntegon Technology GmbH, West Pharmaceutical Services, Inc., OPTIMA packaging group GmbH, IMA Group, Marchesini Group S.p.A., Nipro Corporation, Schott AG (Carl-Zeiss-Stiftung), and SGD Pharma.



Strategies Deployed in Fill Finish Manufacturing Market

Sep-2022: Becton, Dickinson, and Company introduced D EffivaxTM Glass Prefillable Syringe, a next-era glass prefillable syringe. The new syringe is a new benchmark in performance for vaccine PFS with unique and tightened specifications for cosmetics, processability, contamination, and integrity. Moreover, the new BD EffivaxTM Glass Prefillable Syringe has been developed in partnership with foremost pharmaceutical organizations to fulfill the complicated and evolving demands of vaccine manufacturing.

Sep2022: Gerresheimer joined hands with Stevanato Group, a global provider of drug containment. Together, the companies aimed to design a high-end Ready-To-Use (RTU) solution platform with an initial emphasis on vials, established on Stevanato Group’s dominating EZ-fill technology. Additionally, this collaboration is projected to assist consumers to achieve efficiencies, enhance the quality standard, improve speed to market, decrease total expense of ownership, and support mitigates supply chain risk.

Mar-2022: SGD Pharma unveiled 100H* ml Ready-to-Use (RTU)Type I molded glass vials for aseptic fill/finish of intravenous drug products. The Type I molded glass vials mechanical resistance of developed glass creates this large vial size the first-choice solution for drug developers.

Feb-2022: West Pharmaceutical Services came into a partnership with TECHIN, a Technology Innovation Foundation of IIT Palakkad. Together, the companies aimed to create a MedTech Research Center of Excellence to allow permits to healthcare and medical technology by designing an ecosystem of hospitals, academia, and the industry to encourage local entrepreneurship. Additionally, West’s vast experience and expertise as well as IIT’s special incubation model would revolutionize the development and research in medical technology.

Jun-2021: Marchesini Group completed the acquisition of Cosmatic, a business specializing in technologies for the manufacturing of lipsticks and fill-in cosmetic powders. This acquisition would permit Marchesini to develop its expertise in a segment that utilizes some of the most complicated technologies around the globe of cosmetics.

Oct-2020: SCHOTT teamed up with Credence MedSystems, the drug delivery, and specialty pharmaceutical company. Together, the companies aimed to combine the technologies and deliver the pharmaceutical enterprise with a creative and differentiated portfolio for the delivery of injectable medications through prefilled syringes. Additionally, SCHOTT can even go a step further to develop a new, synergistic, and authorized portfolio for glass and polymer syringe systems responsive to the growing demands of the industry, Schott would deliver the first combined needle safety system on the market with a polymer pre-fillable syringe by combining the Credence Companion technology into SCHOTT TOPPAC syringes.

Nov-2019: SCHOTT came into a partnership with West Pharmaceutical Services, a provider of solutions for injectable drug administration. Through this partnership, the companies aimed to connect the SCHOTT iQ platform with West’s Ready Pack system and would expand to contain other suitable, ready-to-use varieties of West and SCHOTT products. Moreover, together the companies would deliver containment solutions to the industry that lower risk and fulfill the growing regulations across the world.

May-2019: The Marchesini Group took over CMP Pharma, the inspection systems professional. This acquisition would improve Marchesini’s unique range of products, delivering stand-alone devices and whole lines qualified for completely packaging all types of products of the pharmaceutical and cosmetic enterprises from start to finish.

Feb-2019: Optima Pharma launched a MultiUse filler machine, developed to process various types of containers in a flexible and completely automated way. The Optima’s MultiUse Filler is appropriate for lab applications up to medium-sized clusters, which can be handled in a fully automated and flexible way. Moreover, the machine can be transformed to cater to various format dimensio

Scope of the Study

Market Segments covered in the Report:

By End User

• Pharmaceutical & Biopharmaceutical Companies

• Contract Manufacturing Organizations

• Others

By Product

• Consumables

o Prefilled Syringes

Glass

Plastic

o Vials

Glass

Plastic

o Cartridges

o Others

• Instruments

o System

o Machine

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Becton, Dickson, and Company

• Gerresheimer AG

• Syntegon Technology GmbH

• West Pharmaceutical Services, Inc.

• OPTIMA packaging group GmbH

• IMA Group

• Marchesini Group S.p.A.

• Nipro Corporation

• Schott AG (Carl-Zeiss-Stiftung)

• SGD Pharma

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Pharmaceutical & Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • $ 4900
  • December 2022
  • 112 pages

Pharmaceutical & Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 By Sector (Pharmaceutical, Biopharmaceutical), By Product Type ...

  • World
  • Pharmaceutical
  • Biopharmaceutical
  • Industry analysis
  • Pharmaceutical Production
  • Manufacturing Output

Enzymes Global Market Report 2023 $ 5000 February 2023


ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on